Ligand Pharmaceuticals (LGND) - Stock price history

Stock price history of Ligand Pharmaceuticals from 1992 to 2025

Annual Stock Price Performance

Year	Performance
2025	68.91%
2024	48.18%
2023	8.16%
2022	-29.35%
2021	52.82%
2020	-5.05%
2019	-23.88%
2018	-2.11%
2017	33.59%
2016	-0.84%
2015	101.79%
2014	3.28%
2013	153.86%
2012	74.14%
2011	32.04%
2010	-31.49%
2009	-19.63%
2008	-43.62%
2007	-40.95%
2006	-4.78%
2005	-0.45%
2004	-22.04%
2003	168.56%
2002	-68.50%
2001	30.18%
2000	0.90%
1999	15.08%
1998	-8.82%
1997	-16.17%
1996	43.37%
1995	34.38%
1994	-31.25%
1993	-4.08%
1992	-14.29%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Amgen AMGN	270,19 €	-0.02%	🇺🇸 USA
Spectrum Pharmaceuticals SPPI	0,88 €	0.00%	🇺🇸 USA
GlaxoSmithKline GSK	41,57 €	-0.13%	🇬🇧 UK
Merck MRK	84,96 €	0.77%	🇺🇸 USA
Pfizer PFE	21,97 €	0.00%	🇺🇸 USA
Eli Lilly LLY	872,74 €	1.54%	🇺🇸 USA
Bristol-Myers Squibb BMY	44,62 €	2.35%	🇺🇸 USA
Baxter BAX	16,18 €	0.56%	🇺🇸 USA
Johnson & Johnson JNJ	180,29 €	0.82%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Ligand Pharmaceuticals (LGND)